Algert Global’s Amgen AMGN Stock Holding History

Algert Global’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-971	Closed	-$303K	–	1178
2025 Q1	$303K	Sell	971 -64	-6%	-$18.9K	0.01%	1009
2024 Q4	$270K	Buy	1,035 +212	+26%	+$62.9K	0.01%	1012
2024 Q3	$265K	Buy	+823	New	+$269K	0.01%	1025

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Algert Global's AMGN Position: Q2 2025 in Review

Algert Global sold out of Amgen (AMGN) in Q2 2025, closing a stake of 971 shares — an estimated $303K sold.

Algert Global first reported a position in AMGN in Q3 2024 and held it in 3 quarters. The position peaked at $303K in Q1 2025. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

Algert Global reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
Algert Global sold 971 Amgen shares in Q2 2025, an estimated $303K.
Algert Global first reported a position in Amgen in Q3 2024 and held it in 3 quarters.
Algert Global's Amgen position peaked at $303K in Q1 2025.
2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Algert Global's 13F filing for Q2 2025, filed 14 Aug 2025.